These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 3085266

  • 1. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK, Tran-Thang C, Bachmann F.
    Thromb Haemost; 1986 Feb 28; 55(1):65-9. PubMed ID: 3085266
    [Abstract] [Full Text] [Related]

  • 2. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK, Tran-Thang C, Bachmann F.
    Thromb Haemost; 1986 Apr 30; 55(2):201-5. PubMed ID: 2940723
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M, Philips M, Thorsen S, Selmer J, Zeuthen J.
    Thromb Haemost; 1987 Oct 28; 58(3):872-8. PubMed ID: 3124286
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR, van den Berg BM, Moestrup SK, Pannekoek H, van Zonneveld AJ.
    Thromb Haemost; 1998 Nov 28; 80(5):822-8. PubMed ID: 9843178
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
    Verheijen JH, Chang GT, Kluft C.
    Thromb Haemost; 1984 Jul 29; 51(3):392-5. PubMed ID: 6437006
    [Abstract] [Full Text] [Related]

  • 12. Increased plasminogen activator inhibition levels in malignancy.
    de Jong E, Knot EA, Piket D, Iburg AH, Rijken DC, Veenhof KH, Dooijewaard G, ten Cate JW.
    Thromb Haemost; 1987 Apr 07; 57(2):140-3. PubMed ID: 3110994
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 07; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
    Urdén G, Johansson U, Chmielewska J, Brandt J, Wiman B.
    Thromb Haemost; 1986 Jun 30; 55(3):383-7. PubMed ID: 3092395
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.